Clinical trial · Observational
Role of Cytochrome P450 2D6 (CYP2D6) *4 Polymorphism,in Malignant Breast Diseases
Role of Cytochrome P450 2D6 (CYP2D6) *4 Polymorphism, Oxidative Stress and Ferretin in Benign and Malignant Breast Diseases
NCT00539422CI-TRIAL-00000903completedClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
The aim of our study is to investigate the potential role of the CYP2D6\*4 polymorphism in breast cancer and furthermore to assess the role of oxidative stress, antioxidant capacity and ferretin in pathogenesis of breast cancer in different CYP2D6\*4 genotypes
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Breast Cancer | Malignant Breast Neoplasm | CURATED_EXACT | 0.92 |
Interventions
Interventions (1)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| pcr and serum markers for breast cancer | Genetic | — | UNRESOLVED |
Design
Arms and outcomes
Arms (3)
- label
- I
- description
- group I of 15 women with benign breast lesion
- interventionNames
- Genetic: pcr and serum markers for breast cancer
- label
- II
- description
- group II of 16 women with breast cancer
- interventionNames
- Genetic: pcr and serum markers for breast cancer
- label
- III
- description
- 13 women were taken as a control group
- interventionNames
- Genetic: pcr and serum markers for breast cancer
Primary outcomes (0)
[]Eligibility
Eligibility (as posted)
- Sex
- Female
- Minimum age
- 33 Years
- Maximum age
- 63 Years
Show eligibility criteria text
Inclusion Criteria: * This study included 31 women admitted to the general surgery department, Mansoura University Hospital. group I consists of 15 women with benign breast lesion, group II composed of 16 women with cancer breast and 13 healthy women with matched age and clinically free were taken as a control group.
References
Publications (0)
Data not yet available
No reference posted for this study.